EPCAM and neoplasm: Notably, EpCAM exhibits high expression levels in various cancers, tumor-initiating cells, and circulating tumor cells (Keller et al., 2019; Menyailo et al., 2021; Agnoletto et al., 2021), and is therefore considered a promising therapeutic target for cancer treatment.